Covid-19: an audacious move to boost kids aged 5-11yrs
blog.maryannedemasi.com
By Maryanne Demasi, PhD This week, the US Food and Drug Administration (FDA) authorised the use of a single booster of Pfizer’s covid-19 vaccine in children aged 5-11, at least five months after completion of a primary series of vaccinations. The CDC’s advisory committee is expected to rubber stamp the decision today.
Covid-19: an audacious move to boost kids aged 5-11yrs
Covid-19: an audacious move to boost kids…
Covid-19: an audacious move to boost kids aged 5-11yrs
By Maryanne Demasi, PhD This week, the US Food and Drug Administration (FDA) authorised the use of a single booster of Pfizer’s covid-19 vaccine in children aged 5-11, at least five months after completion of a primary series of vaccinations. The CDC’s advisory committee is expected to rubber stamp the decision today.